Cisplatin, Intensity-Modulated Radiation Therapy, and Pembrolizumab in Treating Patients With Stage III-IV Head and Neck Squamous Cell Carcinoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Julie E Bauman
NRG Oncology
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
69 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Banner University Medical Center - Tucson
Tucson, Arizona, United States
- Uc San Diego Moores Cancer Center
La Jolla, California, United States
- Cedars Sinai Medical Center
Los Angeles, California, United States
- Sutter Medical Center Sacramento
Sacramento, California, United States
- University of Colorado Hospital
Aurora, Colorado, United States
- Penrose-Saint Francis Healthcare
Colorado Springs, Colorado, United States
- Poudre Valley Hospital
Fort Collins, Colorado, United States
- Yale University
New Haven, Connecticut, United States
- Christiana Care Health System-Christiana Hospital
Newark, Delaware, United States
- Helen F Graham Cancer Center
Newark, Delaware, United States
- Um Sylvester Comprehensive Cancer Center at Coral Gables
Coral Gables, Florida, United States
- Um Sylvester Comprehensive Cancer Center at Deerfield Beach
Deerfield Beach, Florida, United States
- University of Florida Health Science Center - Gainesville
Gainesville, Florida, United States
- University of Miami Miller School of Medicine-Sylvester Cancer Center
Miami, Florida, United States
- Emory University Hospital Midtown
Atlanta, Georgia, United States
- Emory University Hospital/winship Cancer Institute
Atlanta, Georgia, United States
- Grady Health System
Atlanta, Georgia, United States
- Rush - Copley Medical Center
Aurora, Illinois, United States
- Northwestern University
Chicago, Illinois, United States
- Rush University Medical Center
Chicago, Illinois, United States
- Decatur Memorial Hospital
Decatur, Illinois, United States
- Methodist Medical Center of Illinois
Peoria, Illinois, United States
- Osf Saint Francis Medical Center
Peoria, Illinois, United States
- Carle Cancer Center
Urbana, Illinois, United States
- Franciscan Health Indianapolis
Indianapolis, Indiana, United States
- Iowa Methodist Medical Center
Des Moines, Iowa, United States
- University of Kansas Cancer Center
Kansas City, Kansas, United States
- University of Kansas Cancer Center-Overland Park
Overland Park, Kansas, United States
- the James Graham Brown Cancer Center at University of Louisville
Louisville, Kentucky, United States
- Ochsner Medical Center Jefferson
New Orleans, Louisiana, United States
- Henry Ford Cancer Institute-Downriver
Brownstown, Michigan, United States
- Henry Ford Macomb Hospital-Clinton Township
Clinton Township, Michigan, United States
- Henry Ford Hospital
Detroit, Michigan, United States
- Sanford Joe Lueken Cancer Center
Bemidji, Minnesota, United States
- Mayo Clinic in Rochester
Rochester, Minnesota, United States
- the University of Kansas Cancer Center-South
Kansas City, Missouri, United States
- University of Kansas Cancer Center - North
Kansas City, Missouri, United States
- University of Kansas Cancer Center - Lee'S Summit
Lee's Summit, Missouri, United States
- Nebraska Methodist Hospital
Omaha, Nebraska, United States
- Dartmouth Hitchcock Medical Center
Lebanon, New Hampshire, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Nov 2016
- Primary completion
- 3 Dec 2018
- Completion
- 20 May 2022
- Last update posted
- 10 Jun 2022
- Registered enrollment
- 37
- Registry id
- NCT02775812
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.